GLP-1 nausea vs. illness: Can you actually tell the difference?

What did @____britaylor actually say?

Three days into her first dose of Zepbound (tirzepatide), she reported zero side effects on day one, then a rough day two dominated by sulfur burps, which she attributed partly to her pre-existing acid reflux. She also described eating only three all-you-can-eat crabs before feeling stuffed, compared to her usual dozen. "When they say it really suppresses your appetite, they're not kidding," she said. She took Pepcid for the burps and reported no vomiting.

She was also dealing with a stomach bug at the time of posting, which she acknowledged in her caption, making it genuinely difficult to separate drug side effects from viral illness. That transparency is worth noting. She did not overclaim causation, and she was upfront that day three is early days.

Does the science back this up?

Mostly, yes. The GI side effects she described are well-documented in the tirzepatide trial data. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) found that nausea, vomiting, diarrhea, and constipation were the most common adverse events, reported by roughly 30-40% of participants on higher doses. Sulfur burps specifically are not a formal clinical endpoint, but they are a widely reported patient experience linked to delayed gastric emptying, a known mechanism of GLP-1 and GIP receptor agonists.

The appetite suppression she described is also consistent with the pharmacology. Tirzepatide acts on both GLP-1 and GIP receptors, and research suggests dual agonism produces stronger satiety signaling than GLP-1 alone (Frias et al., 2021, Lancet). Feeling full after a tiny meal on day two or three is biologically plausible, though individual variation is significant.

What did they get wrong (or right)?

She got more right than wrong. The sulfur burp connection to reflux history is reasonable. People with pre-existing upper GI conditions do appear to experience more pronounced GI side effects on GLP-1 based therapies, though large controlled data isolating this subgroup is limited.

The one area worth scrutinizing: she described taking Pepcid (famotidine) that was "left over from a long time ago." Using expired or old medication is not automatically dangerous, but it is not a practice a clinician would recommend, and efficacy of degraded famotidine is uncertain. This was a minor aside, but worth flagging.

She did not claim Zepbound cures anything, did not recommend a dose, and did not stack it with anything concerning. The content was personal experience, not medical advice, and she framed it accordingly. That is a lower-risk content format than many GLP-1 videos circulating on TikTok.

What should you actually know?

Early GI side effects on tirzepatide are common and tend to peak in the first few weeks before improving. A 2023 review by Kushner et al. in Obesity Reviews noted that tolerability generally improves with slow titration, which is why most prescribing protocols start at 2.5 mg for four weeks before escalating.

Sulfur burps, specifically, are linked to hydrogen sulfide production when food sits in the stomach longer than usual due to slowed gastric motility. This is not dangerous, but it is unpleasant, and it is a real and underreported side effect that patients deserve to know about before starting.

If you have existing GERD, Barrett's esophagus, or a history of gastroparesis, these drugs warrant a more careful conversation with your provider before starting. The FDA label includes gastroparesis as a potential risk.

Is there anything missing from this video?

Yes. She never mentioned that tirzepatide is contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. That is a standard disclosure in any responsible GLP-1 content. She also did not mention that mixing an active GI illness with a new GLP-1 medication can make dehydration more likely, which is a real clinical concern. Those gaps do not make the video harmful, but they are worth filling in for viewers who are early in their own Zepbound decision-making.